These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

156 related items for PubMed ID: 22204487

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Medicinal chemistry of indolylglyoxylamide GABAA/BzR high affinity ligands: identification of novel anxiolytic/non sedative agents.
    Salerno S, Da Settimo F, Taliani S, Simorini F, La Motta C, Fornaciari G, Marini AM.
    Curr Top Med Chem; 2012; 12(4):286-311. PubMed ID: 22204484
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. From the pharmacophore to the homology model of the benzodiazepine receptor: the indolyglyoxylamides affair.
    Cosimelli B, Cosconati S, Marinelli L, Novellino E, Greco G.
    Curr Top Med Chem; 2012; 12(4):321-32. PubMed ID: 22204482
    [Abstract] [Full Text] [Related]

  • 5. Computational studies on translocator protein (TSPO) and its ligands.
    Ortore G, Tuccinardi T, Martinelli A.
    Curr Top Med Chem; 2012; 12(4):352-9. PubMed ID: 22204485
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. The indolylglyoxylamide scaffold as an useful tool to obtain anxiolytic agents.
    Taliani S, Da Settimo F.
    Curr Top Med Chem; 2012; 12(4):236-7. PubMed ID: 22204480
    [No Abstract] [Full Text] [Related]

  • 8. Anxiolytic properties of a 2-phenylindolglyoxylamide TSPO ligand: Stimulation of in vitro neurosteroid production affecting GABAA receptor activity.
    Costa B, Da Pozzo E, Chelli B, Simola N, Morelli M, Luisi M, Maccheroni M, Taliani S, Simorini F, Da Settimo F, Martini C.
    Psychoneuroendocrinology; 2011 May; 36(4):463-72. PubMed ID: 20728278
    [Abstract] [Full Text] [Related]

  • 9. Translocator protein as a promising target for novel anxiolytics.
    Costa B, Da Pozzo E, Martini C.
    Curr Top Med Chem; 2012 May; 12(4):270-85. PubMed ID: 22204481
    [Abstract] [Full Text] [Related]

  • 10. Design, Synthesis and Anxiolytic Activity Evaluation of N-Acyltryptophanyl- Containing Dipeptides, Potential TSPO Ligands.
    Gudasheva TA, Deeva OA, Mokrov GV, Dyabina AS, Yarkova MA, Seredenin SB.
    Med Chem; 2019 May; 15(4):383-399. PubMed ID: 30457052
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Translocator protein ligands as promising therapeutic tools for anxiety disorders.
    Taliani S, Da Settimo F, Da Pozzo E, Chelli B, Martini C.
    Curr Med Chem; 2009 May; 16(26):3359-80. PubMed ID: 19548867
    [Abstract] [Full Text] [Related]

  • 13. Novel N-(arylalkyl)indol-3-ylglyoxylylamides targeted as ligands of the benzodiazepine receptor: synthesis, biological evaluation, and molecular modeling analysis of the structure-activity relationships.
    Primofiore G, Settimo FD, Taliani S, Marini AM, Novellino E, Greco G, Lavecchia A, Besnard F, Trincavelli L, Costa B, Martini C.
    J Med Chem; 2001 Jul 05; 44(14):2286-97. PubMed ID: 11428922
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. TSPO ligand residence time influences human glioblastoma multiforme cell death/life balance.
    Costa B, Da Pozzo E, Giacomelli C, Taliani S, Bendinelli S, Barresi E, Da Settimo F, Martini C.
    Apoptosis; 2015 Mar 05; 20(3):383-98. PubMed ID: 25413799
    [Abstract] [Full Text] [Related]

  • 16. An update into the medicinal chemistry of translocator protein (TSPO) ligands.
    Barresi E, Robello M, Costa B, Da Pozzo E, Baglini E, Salerno S, Da Settimo F, Martini C, Taliani S.
    Eur J Med Chem; 2021 Jan 01; 209():112924. PubMed ID: 33081988
    [Abstract] [Full Text] [Related]

  • 17. Structure-Dependent Activity of Natural GABA(A) Receptor Modulators.
    Çiçek SS.
    Molecules; 2018 Jun 22; 23(7):. PubMed ID: 29932138
    [Abstract] [Full Text] [Related]

  • 18. Isosteric replacement of amide by ester function. Synthesis and benzodiazepine receptor affinity of indol-3-ylglyoxylyl ester derivatives.
    Da Settimo A, Primofiore G, Marini AM, Da Settimo F, Nuti V, Martini C, Trincavelli L, Lucacchini A.
    Farmaco; 1997 Jun 22; 52(6-7):421-8. PubMed ID: 9372593
    [Abstract] [Full Text] [Related]

  • 19. Synthesis and structure-activity relationship studies in translocator protein ligands based on a pyrazolo[3,4-b]quinoline scaffold.
    Cappelli A, Bini G, Valenti S, Giuliani G, Paolino M, Anzini M, Vomero S, Giorgi G, Giordani A, Stasi LP, Makovec F, Ghelardini C, Di Cesare Mannelli L, Concas A, Porcu P, Biggio G.
    J Med Chem; 2011 Oct 27; 54(20):7165-75. PubMed ID: 21916402
    [Abstract] [Full Text] [Related]

  • 20. Design, synthesis and anxiolytic-like activity of 1-arylpyrrolo[1,2-a]pyrazine-3-carboxamides.
    Mokrov GV, Deeva OA, Gudasheva TA, Yarkov SA, Yarkova MA, Seredenin SB.
    Bioorg Med Chem; 2015 Jul 01; 23(13):3368-78. PubMed ID: 25937237
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.